Genetic damage appears to lie at the heart of tumorigenesis. The damage is of two sorts: dominant, with targets known as proto-oncogenes; and recessive, with targets known as tumor suppressor genes. The work supported by this grant seeks the identity of the damaged genes, their contributions to tumorigenesis, the biochemical mechanisms by which they act, and their roles in the normal cell and organism. Success with these objectives might provide new and more rational strategies for the prevention, diagnosis and therapy of cancer; and it should also reveal principles by which the normal proliferation and differentiation of cells are controlled. The search for additional cancer genes will be conducted in cell culture and transgenic mice, using in particular new strategies for the detection of tumor suppressor genes, with special attention to the distinctive steps in tumor progression, and with a focus on neurological tumors and leukemia. The cancer genes identified to date act by one of three means: protein phosphorylation, signalling by GTPase's, and control of transcription. Each of these will be studied, with emphasis on where they act and how they are controlled in normal cells, how they are integrated into the signalling pathways of the cell, how they figure in cellular proliferation or differentiation, how they serve during organismal development, and how they can contribute to neoplastic transformation. Most attention will be given to the protein-tyrosine kinases encoded by the proto-oncogenes SRC and HCK, and the transcription factors encoded by MYB and MYC. But the products of HRAS, the tumor suppressor genes RB and P53, and the E7 oncogene of Human Papilloma Virus will also be studied. The work will rely on diverse experimental methods, including: molecular cloning, DNA-mediated gene-transfer, retroviral vectors, immunochemistry, biochemical analysis in vitro, site-directed mutagenesis of recombinant DNA, nucleotide sequencing, protein purification, specialized cell culture, molecular screening procedures in yeast, genes made conditional by placing the activity of their protein products under the control of asteroid hormone, genetic analysis in Drosophila melanogaster, and manipulation of genes in mice by homologous recombination - all designed to identify the normal functions of genes in a developing organism and to map the signalling pathways by which these functions are executed.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Unknown (R35)
Project #
5R35CA044338-13
Application #
2894700
Study Section
Special Emphasis Panel (SRC (88))
Program Officer
Cole, John S
Project Start
1987-07-01
Project End
2001-04-30
Budget Start
1999-05-01
Budget End
2000-04-30
Support Year
13
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Yuneva, Mariia O; Fan, Teresa W M; Allen, Thaddeus D et al. (2012) The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type. Cell Metab 15:157-70
Qu, Jian; Bishop, J Michael (2012) Nucleostemin maintains self-renewal of embryonic stem cells and promotes reprogramming of somatic cells to pluripotency. J Cell Biol 197:731-45
Kim, Suwon; Welm, Alana L; Bishop, J Michael (2010) A dominant mutant allele of the ING4 tumor suppressor found in human cancer cells exacerbates MYC-initiated mouse mammary tumorigenesis. Cancer Res 70:5155-62
Field, Kenneth A; Charoenthongtrakul, Soratree; Bishop, J Michael et al. (2008) Farnesyl transferase inhibitors induce extended remissions in transgenic mice with mature B cell lymphomas. Mol Cancer 7:39
He, Chen; Hu, Huiqing; Braren, Rickmer et al. (2008) c-myc in the hematopoietic lineage is crucial for its angiogenic function in the mouse embryo. Development 135:2467-77
Welm, Alana L; Sneddon, Julie B; Taylor, Carmen et al. (2007) The macrophage-stimulating protein pathway promotes metastasis in a mouse model for breast cancer and predicts poor prognosis in humans. Proc Natl Acad Sci U S A 104:7570-5
Braren, Rickmer; Hu, Huiqing; Kim, Yung Hae et al. (2006) Endothelial FAK is essential for vascular network stability, cell survival, and lamellipodial formation. J Cell Biol 172:151-62
Carpenter, Brian; Lin, Yuankai; Stoll, Stephanie et al. (2005) VEGF is crucial for the hepatic vascular development required for lipoprotein uptake. Development 132:3293-303
Kim, Suwon; Chin, Koei; Gray, Joe W et al. (2004) A screen for genes that suppress loss of contact inhibition: identification of ING4 as a candidate tumor suppressor gene in human cancer. Proc Natl Acad Sci U S A 101:16251-6
Yang, Dun; Goga, Andrei; Bishop, J Michael (2004) RNA interference (RNAi) with RNase III-prepared siRNAs. Methods Mol Biol 252:471-82

Showing the most recent 10 out of 78 publications